The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosing indicated for the early stages of ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

The financial challenges facing clinical trials have created a more risk-averse landscape. Yet digital solutions could be the key for sponsors and CROs to optimize budgets and resources. We explore ...

Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North ...